US PTAB IP Litigation
8,722 annotated decisions
Page 34 of 364 · 8,722 total
patent · Oct 1, 2025
MOTORTECH GmbH et al. v.--
· IPR2025-00398
MOTORTECH filed an unopposed motion asking the PTAB to treat its settlement with Altronic as business‑confidential information and keep it separate from the IPR record. The motion cites 35 U.S.C. § 317(b) and seeks limited access to the settlement documents.
patent terminated or settled · Oct 1, 2025
MOTORTECH GmbH et al. v.--
· IPR2025-00398
MotorTech and Altronic have settled their dispute, prompting an unopposed motion to terminate the pending IPR on patent 7,401,603. The Board is asked to end the proceeding under 35 U.S.C. § 317.
patent terminated or settled · Oct 1, 2025
LG Electronics, Inc. et al. v.Maxell, LTD.
· IPR2025-00444
LG Electronics and Maxell have reached a settlement in IPR2025-00444 and jointly moved to terminate the proceeding, requesting that the settlement be treated as business confidential information under statutory authority.
patent terminated or settled · Oct 1, 2025
MOTORTECH GmbH et al. v.--
· IPR2025-00398
MotorTech and Altronic settled their IPR dispute before trial, resulting in the Board terminating the proceeding and keeping the settlement confidential.
patent · Oct 1, 2025
Zhuhai CosMX Battery Co., Ltd. v.Ningde Amperex Technology Ltd.
· IPR2025-00432
Zhuhai CosMX Battery seeks to invalidate Ningde Amperex’s 2023 lithium‑ion battery separator patent by alleging obviousness over multiple prior‑art references. The petition requests the PTAB to institute an IPR under Section 325(d).
patent · Oct 1, 2025
MOTORTECH GmbH et al. v.--
· IPR2025-00398
Motortech has filed an IPR petition seeking cancellation of all 16 claims of U.S. Patent 7,401,603 covering capacitive discharge ignition systems. The petition argues obviousness over a 1992 research disclosure combined with prior patents Grather and Lepley‑I, and disputes any discretionary denial.
patent · Oct 1, 2025
ResMed Corp. v.Cleveland Medical Devices, Inc.
· IPR2025-00246
ResMed has filed a petition for inter partes review seeking to invalidate claims 15‑29 of Cleveland Medical Devices’ ’333 patent covering networked CPAP therapy. The petition alleges obviousness over a combination of prior‑art references Toge, Kumar, Norman and Burton. No secondary considerations are offered and the Board is asked to institute the review.
patent · Oct 1, 2025
Eunsung Global Corp. v.HydraFacial LLC et al.
· IPR2025-00445
Eunsung Global Corp. has filed an IPR petition seeking cancellation of all 17 claims of HydraFacial's microdermabrasion console patent, alleging obviousness over multiple prior‑art references. The petition argues the examiner never considered the cited combinations and that discretionary denial is unwarranted.
patent · Oct 1, 2025
LG Electronics, Inc. et al. v.Maxell, LTD.
· IPR2025-00444
LG Electronics petitions the PTAB to invalidate Maxell’s ’729 electric‑camera patent, arguing that all four claims are obvious over prior‑art cameras. The petition seeks institution of the IPR and cites favorable discretionary‑denial factors.
patent · Oct 1, 2025
ResMed Corp. v.Cleveland Medical Devices, Inc.
· IPR2025-00247
ResMed has filed a petition for inter partes review of Cleveland Medical Devices’ ’029 PAP‑therapy patent, asserting that all 19 claims are obvious over prior‑art PAP devices and telemedicine systems.
patent instituted · Oct 1, 2025
Zhuhai CosMX Battery Co., Ltd. v.Ningde Amperex Technology Ltd.
· IPR2025-00432
Zhuhai CosMX Battery Co., Ltd. successfully demonstrated a reasonable likelihood of success in its IPR against Ningde Amperex Technology Ltd.'s patent, focusing on obviousness under 35 U.S.C. § 103. The Board found that the petitioner adequately showed Murakami discloses key features and that combinations with Beard and Akiike were motivated and predictable.
patent instituted · Oct 1, 2025
ResMed Corp. v.Cleveland Medical Devices, Inc.
· IPR2025-00247
ResMed Corp. successfully convinced the PTAB to institute IPR proceedings against Cleveland Medical Devices regarding a patent covering sleep disorder treatment/CPAP systems. The Board found that ResMed demonstrated a reasonable likelihood of prevailing on Grounds 1-3, which centered on obviousness (35 U.S.C. § 103).
patent instituted · Oct 1, 2025
ResMed Corp. v.Cleveland Medical Devices, Inc.
· IPR2025-00246
ResMed Corp. successfully challenged Cleveland Medical Devices' sleep apnea monitoring patent via IPR, arguing the claims were obvious over combinations of prior art references. The Board found a reasonable likelihood of prevailing on at least one claim, leading to institution.
patent · Sep 30, 2025
Milwaukee Electric Tool Corporation v.Klein Tools, Inc.
· PGR2025-00080
Milwaukee Electric Tool Corp. filed a PGR petition challenging four claims of Klein Tools' safety‑helmet patent, asserting lack of written description, added matter, obviousness over multiple helmet references, and anticipation by Klein's 2019 news release.
patent · Sep 30, 2025
SHENZHEN QIANFENYI INTELLIGENT TECHNOLOGY CO., LTD. v.Wacom Co. Ltd.
· IPR2025-01596
Shenzhen Qianfenyi petitions the PTAB to invalidate Wacom’s 2018 stylus patent, asserting that its tilt‑detection claims are obvious over prior‑art Yoshida combined with either Ikeda or Iguchi. The petition lists two 35 U.S.C. §103 grounds covering 21 claims.
patent · Sep 30, 2025
Samsung Electronics Co., Ltd. et al. v.Massively Broadband LLC
· IPR2025-01594
Samsung Electronics has filed an IPR petition challenging all 39 claims of Massively Broadband’s U.S. Patent 10,224,999, asserting that the claims are obvious over a combination of six prior‑art references.
patent · Sep 30, 2025
Tesla, Inc. v.Perceptive Automata LLC
· IPR2025-01573
Tesla has filed an IPR petition seeking to invalidate all 22 claims of Perceptive Automata’s autonomous‑driving patent, arguing obviousness over multiple prior‑art machine‑learning patents and that many claim elements are non‑patentable printed matter.
patent instituted · Sep 30, 2025
Tesla, Inc. v.Perceptive Automata LLC
· IPR2025-01573
The USPTO granted institution for IPR2025-01573 after determining the petitioner had a reasonable likelihood of prevailing. This decision is part of a broader notice covering multiple institutional decisions.
patent · Sep 29, 2025
Medtronic, Inc. v.Moskowitz Family LLC
· IPR2025-01598
Medtronic has filed an IPR petition challenging claim 43 of U.S. Patent 9,005,293, asserting that the claim is anticipated or obvious over prior‑art spinal‑implant references. The petition highlights alleged nondisclosure of key references during prosecution and deficiencies in the patent’s written description.
patent · Sep 29, 2025
Google LLC v.SoundClear Technologies LLC et al.
· IPR2025-01597
Google has filed an IPR petition challenging claims 1‑5 of SoundClear’s ’337 patent, asserting that prior‑art references Shin, Shimomura and Kristjansson anticipate or make obvious the claimed voice‑controlled device features.
patent · Sep 29, 2025
Samsung Electronics Co., Ltd. et al. v.Massively Broadband LLC
· IPR2025-01595
Samsung Electronics has filed an IPR petition challenging all 26 claims of Massively Broadband's U.S. Patent 8,923,754, asserting that the claims are obvious over a combination of prior‑art references including Ganz, Larrick, Engels, and Perlman.
patent instituted · Sep 29, 2025
Medtronic, Inc. v.Moskowitz Family LLC
· IPR2025-01598
The PTAB granted institution for IPR2025-01598, allowing Medtronic to challenge Moskowitz Family LLC's patent 9005293 at the merits stage.
patent · Sep 26, 2025
WHOOP, Inc. v.Omni MedSci, Inc.
· IPR2025-01584
WHOOP petitions to invalidate claim 7 of Omni MedSci’s ’790 wearable sensor patent, asserting obviousness over multiple prior‑art references and indefiniteness under §112.
patent mixed - some claims cancelled, some upheld · Sep 26, 2025
WHOOP, Inc. v.Omni MedSci, Inc.
· IPR2025-01585
The PTAB held that WHOOP proved unpatentability of 12 of the 23 claims of Omni MedSci’s wearable physiological‑measurement patent, while the remaining 11 claims were left intact. The decision hinged on obviousness over a combination of prior‑art references covering optical sensing, modulation, and AI‑driven analysis.